Redmile Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.16M Sell
85,301
-107,982
-56% -$11.6M 0.98% 24
2025
Q1
$19.5M Sell
193,283
-119,400
-38% -$12M 1.84% 17
2024
Q4
$27.9M Sell
312,683
-18,190
-5% -$1.62M 1.95% 19
2024
Q3
$27.7M Sell
330,873
-59,380
-15% -$4.98M 1.63% 27
2024
Q2
$30.1M Sell
390,253
-170,673
-30% -$13.1M 1.82% 23
2024
Q1
$38.4M Sell
560,926
-132,274
-19% -$9.06M 1.41% 27
2023
Q4
$40.1M Sell
693,200
-81,000
-10% -$4.68M 1.43% 20
2023
Q3
$40.9M Buy
774,200
+383,022
+98% +$20.2M 1.94% 14
2023
Q2
$21.2M Buy
391,178
+219,398
+128% +$11.9M 0.81% 36
2023
Q1
$8.59M Buy
+171,780
New +$8.59M 0.37% 54
2020
Q4
Sell
-1,422,049
Closed -$54.3M 88
2020
Q3
$54.3M Buy
1,422,049
+524,694
+58% +$20M 1% 35
2020
Q2
$31.5M Buy
+897,355
New +$31.5M 0.58% 45
2020
Q1
Sell
-1,631,200
Closed -$73.8M 71
2019
Q4
$73.8M Buy
+1,631,200
New +$73.8M 1.76% 20
2017
Q4
Sell
-603,493
Closed -$17.6M 73
2017
Q3
$17.6M Sell
603,493
-491,490
-45% -$14.3M 0.87% 35
2017
Q2
$30.4M Sell
1,094,983
-105,116
-9% -$2.91M 1.85% 20
2017
Q1
$29.8M Buy
1,200,099
+740,594
+161% +$18.4M 1.94% 18
2016
Q4
$9.94M Sell
459,505
-613,133
-57% -$13.3M 0.86% 31
2016
Q3
$25.5M Sell
1,072,638
-157,682
-13% -$3.75M 2.03% 17
2016
Q2
$28.8M Sell
1,230,320
-102,200
-8% -$2.39M 2.75% 13
2016
Q1
$25.1M Sell
1,332,520
-918,500
-41% -$17.3M 2.57% 15
2015
Q4
$41.5M Buy
+2,251,020
New +$41.5M 3.11% 13
2014
Q3
Sell
-10,000
Closed -$128K 55
2014
Q2
$128K Buy
+10,000
New +$128K 0.02% 45